Drug Search Results
More Filters [+]


Alternative Names: pentobarbital, nembutal
Latest Update: 2023-09-15
Latest Update Note: News Article

Product Description

Pentobarbital is a medication used to manage and treat several medical conditions, including seizures, intracranial pressure control, insomnia, and as a pre-anesthetic in the operating room. Pentobarbital works in the central nervous system by binding to gamma-aminobutyric acid (GABA) A subtype receptors. (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK545288/)

Mechanisms of Action: GABA Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Brazil | Canada | Dominican Republic | Egypt | Germany | Hong Kong | Ireland | Korea | Malaysia | Norway | Poland | Taiwan | United States | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pentobarbital

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events